Asensus Surgical Q4 EPS $(0.07), Inline
Asensus Surgical (AMEX:ASXC) reported quarterly losses of $(0.07) per share which met the analyst consensus estimate. This is a 22.22 percent increase over losses of $(0.09) per share from the same period last year.
Earnings Scheduled For February 28, 2022
Companies Reporting Before The Bell
• Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter.
Asensus Surgical Announces Purchase Of Senhance Robotic System By RZD Medicine; No Terms Disclosed
Asensus Surgical, Inc. (NYSE:ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced Private
81 Biggest Movers From Yesterday
Gainers
Evaxion Biotech A/S (NASDAQ: EVAX) shares jumped 95.1% to close at $12.68 on Thursday after dropping over 10% on Wednesday.
55 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Evaxion Biotech A/S (NASDAQ: EVAX) shares climbed 179% to $18.17 after dropping over 10% on Wednesday.
24 Stocks Moving in Thursday’s Pre-Market Session
Gainers
Evaxion Biotech A/S (NASDAQ: EVAX) rose 143.5% to $15.83 in pre-market trading after dropping over 10% on Wednesday.